在恒温缩放过程中,ProSAAS优先从神经元分泌出来,并减少5xFAD小鼠海马中的粉样斑块大小
Samira Mitias1, Nicholas Schaffer1, Saaya Nair1
1Dept. of Neurobiology, Univ. of Maryland School of Medicine, Baltimore, MD.
bioRxiv : the preprint server for biology
|May 7, 2024
概括
在恒常性缩放过程中,ProSAAS蛋白水平会动态调整,以维持神经元功能. 过度表达 proSAAS 减少了阿尔茨海默氏症中的粉样质斑块.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 蛋白质稳定性 蛋白质稳定性
背景情况:
- 阿尔茨海默病 (AD) 涉及β-粉样蛋白的积累,损害神经元健康和突触功能.
- 恒常性缩放是一种神经元反机制,用于网络稳定性,在AD中可能会受到破坏.
- ProSAAS (前分泌颗粒相关蛋白) 是一个伴侣蛋白质,涉及蛋白质稳定,并与恒常性缩放相关.
研究的目的:
- 研究proSAAS在海马蛋白质稳定中的作用及其在阿尔茨海默病中的抗聚合功能.
- 为了比较proSAAS表达动态与其他突触组件在平静缩放期间.
- 评估proSAAS在AD模型中减少粉样蛋白病理学的治疗潜力.
主要方法:
- 西方抹黑和qPCR用于分析在平稳性缩放期间初级神经元中的proSAAS表达.
- 免疫组织化学定位proSAAS在野生类型和5xFAD小鼠海马.
- 在5xFAD小鼠的CA1区域中,向过度表达的proSAAS传递立体毒性病毒载体 (AAV2/1).
主要成果:
- ProSAAS蛋白,但不是mRNA,在恒常性缩放过程中显示出显著的上调,这表明了翻译控制.
- 在脱极化时,ProSAAS表现出突触释放,并定位在海马体内,包括5xFAD小鼠的粉样斑块周围.
- 在5xFAD小鼠中过度表达proSAAS导致粉样斑块负担显著降低.
结论:
- 动态的proSAAS表达对于海马体的蛋白质静态过程和恒常性可塑性至关重要.
- 普罗萨斯具有抗聚合性质,并在阿尔茨海默病中对粉样蛋白病理学起保护作用.
- 在AD中,ProSAAS代表了管理蛋白质聚合的潜在治疗标.
更多相关视频
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
9.3K
08:25Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
Published on: April 19, 2021
3.3K
相关概念视频
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...